MiR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma

Journal of Experimental Medicine

Volumn 210, Issue 4, 2013, Pages 789-803

  Tao, Zhong Hua ^a   Wan, Jin Liang ^a   Zeng, Ling Yao ^b   Xie, Lu ^b   Sun, Hui Chuan ^a   Qin, Lun Xiu ^a   Wang, Lu ^a   Zhou, Jian ^a   Ren, Zheng Gang ^a   Li, Yi Xue ^b   Fan, Jia ^a   Wu, Wei Zhong ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI CENTER FOR BIOINFORMATION TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; MICRORNA; MICRORNA 612; NERVE CELL ADHESION MOLECULE; PROTEIN KINASE B BETA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; AKT2 PROTEIN, HUMAN; PROTEIN KINASE B; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL CARCINOMA; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; BAGG ALBINO MOUSE; CELL STRAIN HEPG2; CLINICAL TRIAL; FEMALE; FOLLOW UP; GENETICS; LIVER TUMOR; MALE; METABOLISM; METASTASIS; NUDE MOUSE; PATHOLOGY; TUMOR INVASION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FOLLOW-UP STUDIES; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, NEOPLASM;

MLCS; MLOWN;

EID: 84878662313     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20120153     Document Type: Article

References (48)

1. Ambros, V. 2004. The functions of animal microRNAs. Nature. 431:350- 355. http://dx.doi.org/10.1038/nature02871
2. Bartel, D.P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281-297. http://dx.doi.org/10.1016/S0092-8674(04)00045-5
3. Bartel, D.P. 2009. MicroRNAs: target recognition and regulatory functions. Cell. 136:215-233. http://dx.doi.org/10.1016/j.cell.2009.01.002
4. Bracken, C.P., P.A. Gregory, N. Kolesnikoff, A.G. Bert, J. Wang, M.F. Shannon, and G.J. Goodall. 2008. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial- mesenchymal transition. Cancer Res. 68:7846-7854. http://dx.doi.org/10.1158/0008-5472.CAN-08-1942
5. Budhu, A., H.L. Jia, M. Forgues, C.G. Liu, D. Goldstein, A. Lam, K.A. Zanetti, Q.H. Ye, L.X. Qin, C.M. Croce, et al. 2008. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology. 47:897-907. http://dx.doi.org/10.1002/hep.22160
6. Castellano, G., G. Malaponte, M.C. Mazzarino, M. Figini, F. Marchese, P. Gangemi, S. Travali, F. Stivala, S. Canevari, and M. Libra. 2008. Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression. Clin. Cancer Res. 14:7470-7480. http://dx.doi.org/10.1158/1078-0432.CCR-08-0870
7. Chaffer, C.L., and R.A. Weinberg. 2011. A perspective on cancer cell metastasis. Science. 331:1559-1564. http://dx.doi.org/10.1126/science.1203543
8. Charafe-Jauffret, E., C. Ginestier, and D. Birnbaum. 2009. Breast cancer stem cells: tools and models to rely on. BMC Cancer. 9:202. http://dx.doi.org/10.1186/1471-2407-9-202
9. Cummins, J.M., Y. He, R.J. Leary, R. Pagliarini, L.A. Diaz Jr., T. Sjoblom, O. Barad, Z. Bentwich, A.E. Szafranska, E. Labourier, et al. 2006. The colorectal microRNAome. Proc. Natl. Acad. Sci. USA. 103:3687-3692. http://dx.doi.org/10.1073/pnas.0511155103
10. Ding, J., S. Huang, S. Wu, Y. Zhao, L. Liang, M. Yan, C. Ge, J. Yao, T. Chen, D. Wan, et al. 2010. Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat. Cell Biol. 12:390-399. http://dx.doi.org/10.1038/ncb2039
11. Fidler, I.J. 2003. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer. 3:453-458. http://dx.doi.org/10.1038/nrc1098
12. Gregory, P.A., A.G. Bert, E.L. Paterson, S.C. Barry, A. Tsykin, G. Farshid, M.A. Vadas, Y. Khew-Goodall, and G.J. Goodall. 2008. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10:593-601. http://dx.doi.org/10.1038/ncb1722
13. Gupta, G.P., and J. Massagué. 2006. Cancer metastasis: building a framework. Cell. 127:679-695. http://dx.doi.org/10.1016/j.cell.2006.11.001
14. He, H., K. Jazdzewski, W. Li, S. Liyanarachchi, R. Nagy, S. Volinia, G.A. Calin, C.G. Liu, K. Franssila, S. Suster, et al. 2005. The role of microRNA genes in papillary thyroid carcinoma. Proc. Natl. Acad. Sci. USA. 102:19075-19080. http://dx.doi.org/10.1073/pnas.0509603102
15. Huang, X.H., Q. Wang, J.S. Chen, X.H. Fu, X.L. Chen, L.Z. Chen, W. Li, J. Bi, L.J. Zhang, Q. Fu, et al. 2009. Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. Hepatol. Res. 39:786-794. http://dx.doi.org/10.1111/j.1872-034X.2009.00502.x
16. Hummel, M., R. Meister, and U. Mansmann. 2008. GlobalANCOVA: exploration and assessment of gene group effects. Bioinformatics. 24:78-85. http://dx.doi.org/10.1093/bioinformatics/btm531
17. Ji, J., J. Shi, A. Budhu, Z. Yu, M. Forgues, S. Roessler, S. Ambs, Y. Chen, P.S. Meltzer, C.M. Croce, et al. 2009. MicroRNA expression, survival, and response to interferon in liver cancer. N. Engl. J. Med. 361:1437- 1447. http://dx.doi.org/10.1056/NEJMoa0901282
18. Jia, H.L., Q.H. Ye, L.X. Qin, A. Budhu, M. Forgues, Y. Chen, Y.K. Liu, H.C. Sun, L. Wang, H.Z. Lu, et al. 2007. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma. Clin. Cancer Res. 13:1133-1139. http://dx.doi.org/10.1158/1078-0432.CCR-06-1025
19. Landgraf, P., M. Rusu, R. Sheridan, A. Sewer, N. Iovino, A. Aravin, S. Pfeffer, A. Rice, A.O. Kamphorst, M. Landthaler, et al. 2007. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 129:1401-1414. http://dx.doi.org/10.1016/j.cell.2007.04.040
20. Li, Y., B. Tian, J. Yang, L. Zhao, X. Wu, S.L. Ye, Y.K. Liu, and Z.Y. Tang. 2004. Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics. J. Cancer Res. Clin. Oncol. 130:460-468. http://dx.doi.org/10.1007/s00432-004-0564-9
21. Li, S., H. Fu, Y. Wang, Y. Tie, R. Xing, J. Zhu, Z. Sun, L. Wei, and X. Zheng. 2009. MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma. Hepatology. 49:1194-1202. http://dx.doi.org/10.1002/hep.22757
22. Liang, L., C.M. Wong, Q. Ying, D.N. Fan, S. Huang, J. Ding, J. Yao, M. Yan, J. Li, M. Yao, et al. 2010. MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Hepatology. 52:1731-1740. http://dx.doi.org/10.1002/hep.23904
23. Lois, C., E.J. Hong, S. Pease, E.J. Brown, and D. Baltimore. 2002. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science. 295:868-872. http://dx.doi.org/10.1126/science.1067081
24. Ma, L., J. Teruya-Feldstein, and R.A. Weinberg. 2007. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 449:682-688. http://dx.doi.org/10.1038/nature06174
25. Nevins, J.R., and A. Potti. 2007. Mining gene expression profiles: expression signatures as cancer phenotypes. Nat. Rev. Genet. 8:601-609. http://dx.doi.org/10.1038/nrg2137
26. Park, S.M., A.B. Gaur, E. Lengyel, and M.E. Peter. 2008. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22:894-907. http://dx.doi.org/10.1101/gad.1640608
27. Polyak, K., and R.A. Weinberg. 2009. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer. 9:265-273. http://dx.doi.org/10.1038/nrc2620
28. Stewart, S.A., I. Ben-Porath, V.J. Carey, B.F. O'Connor, W.C. Hahn, and R.A. Weinberg. 2003. Erosion of the telomeric single-strand overhang at replicative senescence. Nat. Genet. 33:492-496. http://dx.doi.org/10.1038/ng1127
29. Sun, F.X., Z.Y. Tang, K.D. Lui, S.L. Ye, Q. Xue, D.M. Gao, and Z.C. Ma. 1996. Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues. Int. J. Cancer. 66:239-243.
30. Sun, F.X., A.R. Sasson, P. Jiang, Z. An, R. Gamagami, L. Li, A.R. Moossa, and R.M. Hoffman. 1999. An ultra-metastatic model of human colon cancer in nude mice. Clin. Exp. Metastasis. 17:41-48. http://dx.doi.org/10.1023/A:1026442321295
31. Sun, B.S., Q.Z. Dong, Q.H. Ye, H.J. Sun, H.L. Jia, X.Q. Zhu, D.Y. Liu, J. Chen, Q. Xue, H.J. Zhou, et al. 2008. Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma. Hepatology. 48:1834-1842. http://dx.doi.org/10.1002/hep.22531
32. Tan, H.X., Q. Wang, L.Z. Chen, X.H. Huang, J.S. Chen, X.H. Fu, L.Q. Cao, X.L. Chen, W. Li, and L.J. Zhang. 2010. MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell. Med. Oncol. 27:654-660. http://dx.doi.org/10.1007/s12032-009-9264-2
33. Tavazoie, S.F., C. Alarcón, T. Oskarsson, D. Padua, Q. Wang, P.D. Bos, W.L. Gerald, and J. Massagué. 2008. Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 451:147-152. http://dx.doi.org/10.1038/nature06487
34. Thiery, J.P., H. Acloque, R.Y. Huang, and M.A. Nieto. 2009. Epithelialmesenchymal transitions in development and disease. Cell. 139:871-890. http://dx.doi.org/10.1016/j.cell.2009.11.007
35. Thomson, J.M., J. Parker, C.M. Perou, and S.M. Hammond. 2004. A custom microarray platform for analysis of microRNA gene expression. Nat. Methods. 1:47-53. http://dx.doi.org/10.1038/nmeth704
36. Tsai, W.C., P.W. Hsu, T.C. Lai, G.Y. Chau, C.W. Lin, C.M. Chen, C.D. Lin, Y.L. Liao, J.L. Wang, Y.P. Chau, et al. 2009. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology. 49:1571-1582. http://dx.doi.org/10.1002/hep.22806
37. Ventura, A., and T. Jacks. 2009. MicroRNAs and cancer: short RNAs go a long way. Cell. 136:586-591. http://dx.doi.org/10.1016/j.cell.2009.02.005
38. Voorhoeve, P.M., C. le Sage, M. Schrier, A.J. Gillis, H. Stoop, R. Nagel, Y.P. Liu, J. van Duijse, J. Drost, A. Griekspoor, et al. 2006. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell. 124:1169-1181. http://dx.doi.org/10.1016/j.cell.2006.02.037
39. Watanabe, T., A. Takeda, K. Mise, T. Okuno, T. Suzuki, N. Minami, and H. Imai. 2005. Stage-specific expression of microRNAs during Xenopus development. FEBS Lett. 579:318-324. http://dx.doi.org/10.1016/j.febslet.2004.11.067
40. Wong, C.C., C.M. Wong, E.K. Tung, S.L. Au, J.M. Lee, R.T. Poon, K. Man, and I.O. Ng. 2011. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rhokinase 2. Gastroenterology. 140:322-331. http://dx.doi.org/10.1053/j.gastro.2010.10.006
41. Xue, Y.H., X.F. Zhang, Q.Z. Dong, J. Sun, C. Dai, H.J. Zhou, N. Ren, H.L. Jia, Q.H. Ye, and L.X. Qin. 2010. Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinoma. Hepatology. 52:2012-2022. http://dx.doi.org/10.1002/hep.23942
42. Yang, J., and R.A. Weinberg. 2008. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell. 14:818- 829. http://dx.doi.org/10.1016/j.devcel.2008.05.009
43. Yang, B.W., Y. Liang, J.L. Xia, H.C. Sun, L. Wang, J.B. Zhang, Z.Y. Tang, K.D. Liu, J. Chen, Q. Xue, et al. 2008. Biological characteristics of fluorescent protein-expressing human hepatocellular carcinoma xenograft model in nude mice. Eur. J. Gastroenterol. Hepatol. 20:1077-1084. http://dx.doi.org/10.1097/MEG.0b013e3283050a67
44. Yao, J., L. Liang, S. Huang, J. Ding, N. Tan, Y. Zhao, M. Yan, C. Ge, Z. Zhang, T. Chen, et al. 2010. MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology. 51:846-856.
45. Ye, Q.H., L.X. Qin, M. Forgues, P. He, J.W. Kim, A.C. Peng, R. Simon, Y. Li, A.I. Robles, Y. Chen, et al. 2003. Predicting hepatitis B viruspositive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat. Med. 9:416-423. http://dx.doi.org/10.1038/nm843
46. Zhang, X., S. Liu, T. Hu, S. Liu, Y. He, and S. Sun. 2009. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology. 50:490-499. http://dx.doi.org/10.1002/hep.23008
47. Zhou, J., and W. Wang. 2011. Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell. J. Surg. Oncol. 104:278-283. http://dx.doi.org/10.1002/jso.21941
48. Zhu, X.D., J.B. Zhang, P.Y. Zhuang, H.G. Zhu, W. Zhang, Y.Q. Xiong, W.Z. Wu, L. Wang, Z.Y. Tang, and H.C. Sun. 2008. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J. Clin. Oncol. 26:2707-2716. http://dx.doi.org/10.1200/JCO.2007.15.6521